Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial by Hill, L, Clements, MN, Turner, MA, Dona, D, Lutsar, I, Jacqz-Aigrain, E, Heath, P, Roilides, E, Rawcliffe, L, Alonso-Diaz, C, Baraldi, E, Dotta, A, Ilmoja, M-L, Mahaveer, A, Metsvaht, T, Mitsiakos, G, Papevangelou, V, Sarafidis, K, Walker, AS, Sharland, M

Towards understanding global patterns of antimicrobial use and resistance in neonatal sepsis: insights from the NeoAMR network by Li, G, Bielicki, JA, Ahmed, ASMNU, Islam, MS, Berezin, EN, Gallacci, CB, Guinsburg, R, Da Silva Figueiredo, CE, Vieira, R, Silva, AR, Teixeira, C, Turner, P, Nhan, L, Orrego, J, Pérez, PM, Qi, L, Papaevangelou, V, Triantafyllidou, P, Iosifidis, E, Roilides, E, Sarafidis, K, Jinka, DR, Nayakanti, RR, Kumar, P, Gautam, V, Prakash, V, Seeralar, A, Murki, S, Kandraju, H, Singh, S, Kumar, A, Lewis, L, Pukayastha, J, Nangia, S, N, Y, Chaurasia, S, Chellani, H, Obaro, S, Dramowski, A, Bekker, A, Whitelaw, A, Thomas, R, Velaphi, SC, Ballot, DE, Nana, T, Reubenson, G, Fredericks, J, Anugulruengkitt, S, Sirisub, A, Wong, P, Lochindarat, S, Boonkasidecha, S, Preedisripipat, K, Cressey, TR, Paopongsawan, P, Lumbiganon, P, Pongpanut, D, Sukrakanchana, P-O, Musoke, P, Olson, L, Larsson, M, Heath, PT, Sharland, M